** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise 1.5% to $72.60
** Raises 2025 per-share profit forecast to between $6.27 and $6.62, compared with between $6.12 and $6.49 earlier
** Expects full-year revenue of $768 million-$793 million, compared with previously projected $756 million-$776 million
** Quarterly revenue jumped 43.4% to $197.1 million, above analysts' estimates of $180.68 million - data compiled by LSEG
** Including session's moves, stock up 33% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.